Sign Up to like & get
recommendations!
0
Published in 2024 at "Applied Sciences"
DOI: 10.3390/app14072827
Abstract: From 1993 to 2013, tacrine was an approved drug for Alzheimer’s disease. Due to its strong inhibitory properties towards cholinesterase, tacrine causes an increase in the level of the neurotransmitter acetylcholine in the cholinergic system…
read more here.
Keywords:
alzheimer disease;
diagnosis;
based tacrine;
tacrine derivatives ... See more keywords